“Despite the near-term uncertainty with U.S. federal spending, this company is making an impact with customers while delivering durable, profitable growth and outstanding free cash flow.” (Adam Clammer, Chairman)
“We see 2025 playing out largely as originally planned in the majority of our businesses with the U.S. state and local government and Latin America positioned actually to deliver exceptional full year results.” (CEO)
“Based on the ongoing dialogue with our customers, we expect these needs will lead to a resurgence of growth in 2026.” (CEO)
“We are planning for temporary delays with U.S. federal agencies. While customer interest and engagement in this sector is high, we’re planning it will take time before the recent U.S. legislation will help drive higher spending on Cellebrite by U.S. federal agencies.” (CFO)
“I’d like to reiterate our view that 2025 will be an excellent year for free cash flow.” (CFO)
Prepared Metrics
Metric
Value
Speaker/Context
ARR (Q2 2025)
$419M
CFO
ARR增长
21% YoY
CFO
总收入 (Q2 2025)
$113.3M
CFO
收入增长
18% YoY
CFO
订阅收入增长
21% YoY
CFO
毛利率
85%
CFO
调整后 EBITDA
$27.9M
CFO
调整后 EBITDA 利润率
24.6%
CFO
自由现金流 (Q2)
$29M
CFO
自由现金流利润率 (Q2)
25.6%
CFO
过去十二个月自由现金流
$150M
CFO
现金、现金等价物及投资
$558M
CFO
Inseyets 部署率
>40% of license base
CEO
云/SaaS 占 ARR
20%
CFO
Guardian ARR 增长
>100% YoY (连续第4个季度)
CEO
员工总数
1,216
CFO
Q&A Batch (1-5 of 5)
Q1 — Shaul Eyal
Topic: 联邦支出复苏信心与客户留存率
Key points:
管理层对联邦业务信心“很高”,描述为“当复苏到来时,将非常猛烈”(with a vengeance)。